Israeli Firm Nucleai Raises $33M For Its AI Pathology Platform
Nucleai’s vision is to bring spatial biology to the forefront of precision medicine and embed its platform in every clinical trial involving tissue.
March 22, 2022
Israeli Startup Nucleai Partners With Sheba Hospital For AI Pathology Program
The Nucleai team will have access to Sheba Medical Center's extensive repository of pathology, clinical, and other multi-omics data.
March 08, 2021
Israeli Startup Nucleai Raises $6.5M For Its AI Precision Oncology System
Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.
July 08, 2020
7 Recent Israeli Breakthroughs In Cancer Research And Detection
From AI algorithms set to transform diagnoses to new urine and blood tests, these are the cancer-related developments so far this year
April 12, 2018